Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduce steroids in relapsing nephrotic syndrome (children)
2016-002430-76Phase 4Active
- Sponsor
- Radboudumc
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nephrosis comparing Standard prednisolone regimen with Reduced prednisolone regimen plus placebo (2 arms). Primary endpoints: Time to first relapse at 12 months and Time to first relapse at 24 months. Started Nov 2016; status: active.
02
Drugs
prednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2016-002430-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002430-76.